How do we solve population pressure and climate crisis in space? How has GPS allowed us to provide 12% more food globally? How did the UK become a global leader in small satellite manufacture after the British Government said, “there’s no future for the UK satellite industry”? How did Elon Musk turn reusable rockets from science fiction to science fact in less than 20 years? What else are “Elon and Jeff” going to allow us to do? And why is SpaceX still “the elephant in the room”?

Join Alice as she talks to Will Whitehorn, chair of giant space tech investor Seraphim and former president of Virgin Galactic, and they discuss the implications of “The Elon Musk show” and its legacy, “the beginnings of a competitive space industry of scale”.

Contributors:

Alice Bunn, President of UKspace

Dr Alice Bunn OBE FIMechE FRAeS CEng | LinkedIn

UKspace: Overview | LinkedIn

Will Whitehorn OBE, Seraphim Space Investment Trust

Will Whitehorn OBE | LinkedIn

Key topics covered:

• UK satellite manufacture
• UK universities
• SpaceX valuation
• Reuseable rockets
• Agricultural management
• Population pressure
• Climate crisis
• Solar power
• Data centres in space
• Industrialising in space

Hosted on Acast. See acast.com/privacy for more information.

Up to one-third of patients with a previous asthma diagnosis show no evidence of the condition upon further evaluation – so GPs should be prepared to re-evaluate, according to respiratory GP Dr Steve Holmes.

Dr Holmes says: ‘When I see somebody and I think it’s asthma but the FeNO is normal and the eosinophils are normal, and then I send them for spirometry and that test is normal too, quite often at each time they come back with those normal results, I’m re-evaluating whether it is actually asthma or not.’

As well as asthma diagnosis, this podcast covers current challenges in asthma management, including overuse of short-acting bronchodilator inhalers, and the shift towards maintenance and reliever therapy (MART) and on-demand anti-inflammatory reliever (AIR) therapy. Dr Holmes also touches on current developments in management of COPD, and pitfalls in acute respiratory assessment.

Educational objectives

After listening to this podcast, healthcare professionals should be better able to:

• Recall the percentage of people with an asthma diagnosis who do not actually have asthma
• Ensure that they are following guideline-based recommendations for asthma diagnosis
• Proactively find patients who are overusing short-acting bronchodilator inhalers
• Reflect on how best to transfer patients to MART and AIR therapy
• Consider how to promote face-to-face inhaler technique coaching by healthcare professionals
• Identify normalised breathlessness so as to pick up more cases of COPD
• Consider how to identify COPD patients who might benefit from referral for biologic therapy
• Prioritise respiratory rate in acute assessment, and be aware of the limitations of pulse oximeters

You can access the website version of this podcast, along with a list of key learning points, on MIMS Learning - and make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.

Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.

Useful resources

MIMS Learning

Guidance update: BTS/NICE/SIGN guidelines on diagnosis, monitoring and chronic asthma management

Challenges in respiratory care learning plan

MIMS

MIMS table on asthma and COPD preparations and compatible devices

Hosted on Acast. See acast.com/privacy for more information.

What did the Space-Comm Expo conference and exhibition tell us about connecting space and wider business? How does this manifest as tech connectivity in telecoms and why do farmers care about that? What did we learn about the benefits of extreme cold in manufacturing laboratories and why do pharmas care about that? How vulnerable are global logistics to the spoofing of navigation signals? And why is the UK government centralising space strategy in the Department for Science, Innovation and Technology?

Join Alice and Jonners as they reflect on the UK space sector’s largest trade event and the “energy, diversity and …sheer scope of what this industry has to offer”.

Contributors:

Alice Bunn, President of UKspace

Dr Alice Bunn OBE FIMechE FRAeS CEng | LinkedIn

UKspace: Overview | LinkedIn

Jonathan Daves, The Karman Line

Jonathan Daves | LinkedIn

Subscribe to The Karman Line

Apple: https://podcasts.apple.com/ca/podcast/the-k%C3%A1rm%C3%A1n-line/id1876605462

Spotify: https://open.spotify.com/show/3qED4CgdRDxfKKzYNKZCIH?si=lZ-I4a19SPGLAJL-dHi4DQ

YouTube: https://www.youtube.com/@TheKármánLineUK

Key topics covered:

Space-Comm Expo, London, March 2026

Conference overview

Sector integration

Insurance

Customer utility

Government role

Future outlook

Technological advancements

· Telecoms

· Manufacturing

Defence and security

· Satellite capabilities

· Current threats

Hosted on Acast. See acast.com/privacy for more information.